Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. (Q53145586)
Jump to navigation
Jump to search
scientific article published on 18 September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. |
scientific article published on 18 September 2011 |
Statements
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. (English)
1 reference
Linda-Gail Bekker
1 reference
Christine Katlama
1 reference
Joseph J Eron
1 reference
Jürgen K Rockstroh
1 reference
Jacques Reynes
1 reference
Jaime Andrade-Villanueva
1 reference
Jose Valdez Ramalho-Madruga
1 reference
Benjamin Young
1 reference
Jose Maria Gatell-Artigas
1 reference
Mark Nelson
1 reference
Havilland Campbell
1 reference
Jing Zhao
1 reference
Anthony J Rodgers
1 reference
Matthew L Rizk
1 reference
Larissa Wenning
1 reference
Michael D Miller
1 reference
Daria Hazuda
1 reference
Mark J DiNubile
1 reference
Randi Leavitt
1 reference
Robin Isaacs
1 reference
Michael N Robertson
1 reference
Peter Sklar
1 reference
Bach-Yen Nguyen
1 reference
QDMRK Investigators
1 reference
18 September 2011
1 reference
11
1 reference
12
1 reference
907-915
1 reference
Identifiers
1 reference